Introduction and marketing status of diazepam oral film
Diazepam oral film is a new delivery form of diazepam, mainly used to treat acute epileptic seizures. It adopts a film-like design that can quickly absorb drugs through the oral mucosa, thereby shortening the onset of action and avoiding the dependence of traditional oral drugs on the gastrointestinal tract. Not only does this delivery method improve patient compliance, it is also particularly useful for patients who are unable to swallow pills or who need to quickly control epileptic seizures.
In terms of marketing, diazepam oral film has been approved by the U.S. Food and Drug Administration (FDA) and is marketed under the brand name "Valtoco" for intermittent treatment of epilepsy in patients 6 years old and above. Its research and development goal is to provide a convenient, portable and easy-to-use first aid solution suitable for home, school or other non-medical environments, so that patients or caregivers can quickly respond to emergencies.

Oral film dosage forms offer significant advantages in ease of use compared to traditional diazepam injections or rectal gels. Patients do not need to inject or take medication rectally. They only need to place the medicine film in the mouth to complete the medication, which reduces the discomfort and psychological burden that may be caused during use. In addition, this dosage form can achieve stable blood concentration in a short period of time, improving the reliability of the efficacy.
At present, the marketing area of diazepam oral film is still mainly concentrated in the United States and some European countries, and it has not yet been popularized in all markets. Because it is a specialty drug, a doctor's prescription is usually required when purchasing it. In some countries where it is not yet on the market, patients may need to obtain it through cross-border medical treatment, overseas purchasing or special application channels, but they need to consult a doctor before use to ensure rational medication use and safety.
References: https://www.yaozui.com/medicine/di-xi-pan-kou-qiang-mo-ji
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)